ReviewACS omega2026
Two Decades of Nanotoxicology: Evolution, Impact, and Future Challenges.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of nanotechnology, with over 11,100 products and 100,000 patents, has raised safety concerns for organisms and ecosystems. Nanotoxicology emerged from ultrafine particle studies in the 1990s and was formally established in 2004. This review synthesizes approximately 160 publications and regulatory documents, selected from 220 compiled, to analyze the field's evolution from 2004 to 2025. Early studies focused on nanostructures in medicine and their effects on organs and tissues, driving research aimed at mitigating risks. Current studies increasingly address the molecular mechanisms underlying nanostructure toxicity, which arise from dynamic interactions among physicochemical properties, exposure conditions, biological transformations, and environmental fate. Research extends beyond human health to assess long-term environmental impacts. Artificial intelligence and machine learning have enabled predictive models linking physicochemical properties to toxicological outcomes, although reliability remains limited by data set heterogeneity, restricted external validation, and overfitting. Bibliometric analysis revealed a publication peak around 2014-2016 (>380 articles/year), followed by a decline through 2023-2024 and partial recovery in 2025, reflecting diversification into nanosafety, safety-by-design, nanoecotoxicology, and AI-based prediction. Standardized protocols, harmonized data sets, and globally accepted safe exposure limits remain unavailable. Future progress depends on integrating biologically and environmentally relevant models, robust computational approaches, and harmonized regulatory frameworks to advance sustainable nanotechnology.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.